Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
Resources Genes Glycoproteins Lectins Glycolipids Glycans Pathways Diseases Organisms
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
Other Information
Release Statistics Download
Tools
SugarDrawer GlycanBuilder Glycan Converters GlycoMaple GlycomeAtlas LM-GlycomeAtlas GALAXY MCAW GlycoSim GRable
Search Tools
Cross Search Glycan Search Publication Search Programmatic Access
Standards Ontologies Notations
GlycoNAVI Proteins

GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.

Source Last Updated
GlycoNAVI Proteins September 04, 2024
Displaying entries 19701 - 19750 of 39437 in total
PDB ID UniProt ID ▼ Title Descriptor
6ARU P0DOX5 Structure of Cetuximab Fab mutant in complex with EGFR extracellular domain
6ARU P0DOX5 Structure of Cetuximab Fab mutant in complex with EGFR extracellular domain
6FGO P0DOX5 Fc in complex with engineered calcium binding domain Z
6OGE P0DOX5 Cryo-EM structure of Her2 extracellular domain-Trastuzumab Fab-Pertuzumab Fab complex Receptor tyrosine-protein kinase erbB-2 (E.C.2.7.10.1), Pertuzumab Fab - light chain, Pertuzumab Fab - heavy chain, Trastuzumab Fab - light chain, Trastuzumab Fab - heavy chain
6OGE P0DOX5 Cryo-EM structure of Her2 extracellular domain-Trastuzumab Fab-Pertuzumab Fab complex Receptor tyrosine-protein kinase erbB-2 (E.C.2.7.10.1), Pertuzumab Fab - light chain, Pertuzumab Fab - heavy chain, Trastuzumab Fab - light chain, Trastuzumab Fab - heavy chain
7CZT P0DOX5 S protein of SARS-CoV-2 in complex bound with P5A-2G9 Spike glycoprotein, heavy chain of 4A8, light chain of 4A8
7CZT P0DOX5 S protein of SARS-CoV-2 in complex bound with P5A-2G9 Spike glycoprotein, heavy chain of 4A8, light chain of 4A8
5VU0 P0DOX5 Crystal structure of the complex between afucosylated/galactosylated human IgG1 Fc and Fc gamma receptor IIIa (CD16A) with Man5 N-glycans
5W5L P0DOX5 Crystal structure of human IgG1-Sigma Fc fragment
5XJE P0DOX5 Crystal structure of fucosylated IgG1 Fc complexed with bis-glycosylated soluble form of Fc gamma receptor IIIa
5XJF P0DOX5 Crystal structure of fucosylated IgG Fc Y296W mutant complexed with bis-glycosylated soluble form of Fc gamma receptor IIIa
5XMH P0DOX5 Crystal structure of an IgM rheumatoid factor YES8c in complex with IgG1 Fc Immunoglobulin gamma-1 heavy chain, YES8c light chain, YES8c heavy chain
6BZ4 P0DOX5 Human IgG1 lacking complement-dependent cytotoxicity: hu3S193 Fc mutant K322A
6MUB P0DOX5 Anti-HIV-1 Fab 2G12 + Man5 re-refinement
6MUB P0DOX5 Anti-HIV-1 Fab 2G12 + Man5 re-refinement
6UGY P0DOX5 Crystal structure of the Fc fragment of anti-TNFa antibody infliximab (Remicade) in a primative orthorhombic crystal form, Lot C
6UGY P0DOX5 Crystal structure of the Fc fragment of anti-TNFa antibody infliximab (Remicade) in a primative orthorhombic crystal form, Lot C
6X3I P0DOX5 NNAS Fc mutant
7CZV P0DOX5 S protein of SARS-CoV-2 in complex bound with P5A-1B6_3B Spike glycoprotein, heavy chain of 4A8, light chain of 4A8
7CZV P0DOX5 S protein of SARS-CoV-2 in complex bound with P5A-1B6_3B Spike glycoprotein, heavy chain of 4A8, light chain of 4A8
6KA7 P0DOX5 The complex structure of Human IgG Fc and its binding Repebody repebody, Immunoglobulin gamma-1 heavy chain
6UGX P0DOX5 Crystal structure of the Fc fragment of PF06438179/GP1111 an infliximab biosimilar in a primative orthorhombic crystal form, Lot A
6UGX P0DOX5 Crystal structure of the Fc fragment of PF06438179/GP1111 an infliximab biosimilar in a primative orthorhombic crystal form, Lot A
6YSC P0DOX5 GLYCOSYLATED KNOB-HOLE/DUMMY FC FRAGMENT
5WAV P0DOX5 Fc AbVance: Increasing our knowledge of antibody structural space to enable faster and better decision-making in antibody drug discovery. Immunoglobulin gamma-1 heavy chain
5WAV P0DOX5 Fc AbVance: Increasing our knowledge of antibody structural space to enable faster and better decision-making in antibody drug discovery. Immunoglobulin gamma-1 heavy chain
6BKB P0DOX5 Structure of Hepatitis C Virus Envelope Glycoprotein E2 core from genotype 6a bound to broadly neutralizing antibody AR3A
6BKB P0DOX5 Structure of Hepatitis C Virus Envelope Glycoprotein E2 core from genotype 6a bound to broadly neutralizing antibody AR3A
6BKC P0DOX5 Structure of Hepatitis C Virus Envelope Glycoprotein E2 core from genotype 6a bound to broadly neutralizing antibody AR3B
6BKC P0DOX5 Structure of Hepatitis C Virus Envelope Glycoprotein E2 core from genotype 6a bound to broadly neutralizing antibody AR3B
6MSY P0DOX5 Anti-HIV-1 Fab Fab 2G12 + Man4 re-refinement
6MSY P0DOX5 Anti-HIV-1 Fab Fab 2G12 + Man4 re-refinement
6N35 P0DOX5 Anti-HIV-1 Fab 2G12 + Man1-2 re-refinement
6N35 P0DOX5 Anti-HIV-1 Fab 2G12 + Man1-2 re-refinement
6VSL P0DOX5 Crystal structure of a human fucosylated IgG1 Fc expressed in tobacco plants (Nicotiana benthamiana)
6YTB P0DOX5 GLYCOSYLATED KNOB/DUMMY-HOLE/DUMMY FC FRAGMENT
5Y56 P0DOX5 Fc mutant (K392D/K409D/D399K)
6IFJ P0DOX5 Structure of bispecific Fc
6IQG P0DOX5 X-ray crystal structure of Fc and peptide complex
6MU3 P0DOX5 Anti-HIV-1 Fab 2G12 + Man7 re-refinement
6MU3 P0DOX5 Anti-HIV-1 Fab 2G12 + Man7 re-refinement
6UGW P0DOX5 Crystal structure of the Fc fragment of PF06438179/GP1111 an infliximab biosimilar in a C-centered orthorhombic crystal form, Lot A
6UGW P0DOX5 Crystal structure of the Fc fragment of PF06438179/GP1111 an infliximab biosimilar in a C-centered orthorhombic crystal form, Lot A
1HZH P0DOX5 CRYSTAL STRUCTURE OF THE INTACT HUMAN IGG B12 WITH BROAD AND POTENT ACTIVITY AGAINST PRIMARY HIV-1 ISOLATES: A TEMPLATE FOR HIV VACCINE DESIGN IMMUNOGLOBULIN (HEAVY CHAIN, LIGHT CHAIN)
1HZH P0DOX5 CRYSTAL STRUCTURE OF THE INTACT HUMAN IGG B12 WITH BROAD AND POTENT ACTIVITY AGAINST PRIMARY HIV-1 ISOLATES: A TEMPLATE FOR HIV VACCINE DESIGN IMMUNOGLOBULIN (HEAVY CHAIN, LIGHT CHAIN)
3PGF P0DOX5 Crystal structure of maltose bound MBP with a conformationally specific synthetic antigen binder (sAB)
3PGF P0DOX5 Crystal structure of maltose bound MBP with a conformationally specific synthetic antigen binder (sAB)
4R2G P0DOX5 Crystal Structure of PGT124 Fab bound to HIV-1 JRCSF gp120 core and to CD4 Surface protein gp160, T-cell surface glycoprotein CD4, PGT124 Heavy Chain, PGT124 Light Chain
4R2G P0DOX5 Crystal Structure of PGT124 Fab bound to HIV-1 JRCSF gp120 core and to CD4 Surface protein gp160, T-cell surface glycoprotein CD4, PGT124 Heavy Chain, PGT124 Light Chain
5O4E P0DOX5 Crystal structure of VEGF in complex with heterodimeric Fcab JanusCT6 Ig gamma-1 chain C region
Download data in CSV format Download data in TSV format Download data in JSON format
About Release Notes Help Feedback

Click here to visit the beta site.

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01

Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International

GlyCosmos Portal v4.0.0

Last updated: August 19, 2024